Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

2018/04/16 3:28:09 AM

LONDON (Reuters) – Shire , the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical , is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion.

READ Shire sells cancer drugs to Servier for .4 billion as Takeda circles On Reuters

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles

Related Posts